DR. TOM W CHU, M.D.
Medical Practice at Cascade Dr, Sunnyvale, CA
License number
California G84785
Category
Medical Practice
Type
Clinical Genetics (M.D.)
Address
Address
1025 Cascade Dr, Sunnyvale, CA 94087
Phone
(650) 855-5728
Organization information
See more information about TOM W CHU at bizstanding.comDr. Tom W. Chu, MD
1025 Cascade Dr, Sunnyvale, CA 94087
Industry:
Mfg Measuring/Controlling Devices
Medical Doctor, Principal:
Tom W. Chu (Medical Doctor, Principal)
Professional information
Dr. Tom W Chu, Sunnyvale CA - MD (Doctor of Medicine)
Specialties:
Pediatrics, Clinical Genetics
Address:
1025 Cascade Dr, Sunnyvale 94087
Certifications:
Clinical Genetics, 2010, Pediatrics, 1999
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University Of Washington
University Of Washington
Prediction Of Hcv Viral Kinetics In Interferon-Free Treatment
US Patent:
2012019, Aug 2, 2012
Filed:
Jul 29, 2011
Appl. No.:
13/194248
Inventors:
Tom Chu - Sunnyvale CA, US
Uri A. Lopatin - San Francisco CA, US
Nancy Shulman - Palo Alto CA, US
Uri A. Lopatin - San Francisco CA, US
Nancy Shulman - Palo Alto CA, US
Assignee:
ROCHE MOLECULAR SYSTEMS, INC. - Pleasanton CA
International Classification:
C12Q 1/70
US Classification:
435 5
Abstract:
The present invention is based on the discovery of associations that exist between single nucleotide polymorphisms (SNPs) on chromosome 19 and virological outcomes in a diverse population of patients with hepatitis C virus (HCV) who received interferon-free treatment.
Prediction Of Early Virological Response In Hcv Treatment
US Patent:
2012009, Apr 19, 2012
Filed:
Apr 11, 2011
Appl. No.:
13/084216
Inventors:
Uri Lopatin - San Francisco CA, US
Tom Chu - Sunnyvale CA, US
Laurent Essioux - Attenschwiller, FR
Soren Germer - Maplewood NJ, US
Nancy Shulman - Palo Alto CA, US
James A. Thommes - San Francisco CA, US
Tom Chu - Sunnyvale CA, US
Laurent Essioux - Attenschwiller, FR
Soren Germer - Maplewood NJ, US
Nancy Shulman - Palo Alto CA, US
James A. Thommes - San Francisco CA, US
Assignee:
ROCHE MOLECULAR SYSTEMS, INC. - Pleasanton CA
International Classification:
C12Q 1/68, G01N 33/50
US Classification:
435 611, 436 94
Abstract:
The present invention is based on the discovery of associations that exist between single nucleotide polymorphisms (SNPs) on chromosome 19 and virological outcomes in a diverse population of patients with hepatitis C virus (HCV) who received interferon-based treatment.
Single Nucleotide Polymorphisms That Predict Hcv Treatment Outcomes
US Patent:
2012009, Apr 19, 2012
Filed:
Apr 11, 2011
Appl. No.:
13/084187
Inventors:
Uri Lopatin - San Francisco CA, US
Tom Chu - Sunnyvale CA, US
Laurent Essioux - Attenschwiller, FR
Soren Germer - Maplewood NJ, US
Nancy Shulman - Palo Alto CA, US
James A. Thommes - San Francisco CA, US
Tom Chu - Sunnyvale CA, US
Laurent Essioux - Attenschwiller, FR
Soren Germer - Maplewood NJ, US
Nancy Shulman - Palo Alto CA, US
James A. Thommes - San Francisco CA, US
Assignee:
ROCHE MOLECULAR SYSTEMS, INC. - Pleasanton CA
International Classification:
G01N 33/50
US Classification:
436 94
Abstract:
The present invention is based on the discovery of associations that exist between single nucleotide polymorphisms (SNPs) on chromosome 4 and virological outcomes in a diverse population of patients with hepatitis C virus (HCV) who received interferon-based treatment.